Fresh filings dated September 8 show a wave of insider disposals across Asian and European markets. The most eye-catching move came from SUAL Partners, which filed a sale of roughly $331 million worth of shares in RUSAL on August 24. The filing became public two weeks later.
In India, Fosun Pharma Industrial filed two separate sell transactions in Gland Pharma totalling over $296 million. Both trades were executed in early September. Fosun is a promoter-group shareholder, making the continued reduction of its stake worth watching.
South Korean robotics firm ROBOTIS saw its CEO, Kim Byeong Soo, file a $75 million sale on September 8 itself — a same-day filing. That speed is unusual and gives the disclosure extra weight.
On the buy side, NASS Investment Holding stepped in to absorb a $98 million block trade in Egyptian firm EFIC on September 7, matching a same-day sale by MIDFERT Egypt — suggesting a direct stake transfer rather than open-market conviction.
What was unavailable: ORTEX's first-party SEC EDGAR Form 4 tables were not accessible, so US open-market trades could not be checked directly. The activist 13D filing table was also restricted. US insider activity from the past two weeks remains unverified from this dataset.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
